Skip to main content
Top
Published in: Neurocritical Care 3/2010

01-12-2010 | Original Article

Hemicraniectomy for Malignant Middle Cerebral Artery Infarction: Retrospective Consent to Decompressive Surgery Depends on Functional Long-Term Outcome

Authors: Ines C. Kiphuth, Martin Köhrmann, Christoph Lichy, Stefan Schwab, Hagen B. Huttner

Published in: Neurocritical Care | Issue 3/2010

Login to get access

Abstract

Background

Decompressive surgery for malignant middle cerebral artery infarction increases the number of surviving patients; this, however, leaves some patients severely disabled. This study analyzed the patients’ retrospective consent to hemicraniectomy in light of the experienced functional outcome 12 months after hospital stay.

Methods

This retrospective study included all patients who underwent decompressive hemicraniectomy for malignant middle cerebral artery infarction in the Department of Neurology, University of Erlangen, Germany, from January 2006 until March 2009. Data on mortality and functional outcome (measured by the modified Rankin Scale; mRS) 6 and 12 months after treatment were correlated with retrospective consent to hemicraniectomy as well as with a quality of life instrument (EuroQol). Data were obtained by structured telephone interviews with the patients themselves or their closest relatives.

Results

In the study period 28 patients received decompressive surgery. Retrospective consent to hemicraniectomy was 82.1%. Five patients, or their closest relatives, would not agree to hemicraniectomy again, given their functional outcome after 1 year. Two out of two patients who experienced an mRS of 5 would not have consented. Low quality of life was most often declared in this subgroup.

Conclusions

Retrospective consent to hemicraniectomy for treatment of malignant MCA infarction depends on functional long-term outcome. We need to identify those patients who would survive the malignant MCA infarction due to decompressive surgery but only reach a severely reduced functional status.
Literature
1.
go back to reference Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309–15.PubMed Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309–15.PubMed
2.
go back to reference Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology. 1995;45:1286–90.PubMed Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology. 1995;45:1286–90.PubMed
3.
go back to reference Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol. 1984;41:26–9.PubMed Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol. 1984;41:26–9.PubMed
4.
go back to reference Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888–93.PubMed Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888–93.PubMed
5.
go back to reference Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG, DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke. 2007;38:2506–17.CrossRefPubMed Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG, DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke. 2007;38:2506–17.CrossRefPubMed
6.
go back to reference Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W, DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–25.CrossRefPubMed Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W, DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–25.CrossRefPubMed
7.
go back to reference Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery Infarction with Life-Threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326–33.CrossRefPubMed Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery Infarction with Life-Threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326–33.CrossRefPubMed
8.
go back to reference Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W, for the DECIMAL, DESTINY and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–22. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W, for the DECIMAL, DESTINY and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–22.
9.
go back to reference Huttner HB, Schwab S. Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol. 2009;8:949–58.CrossRefPubMed Huttner HB, Schwab S. Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol. 2009;8:949–58.CrossRefPubMed
10.
go back to reference Mitchell P, Gregson BA, Crossman J, Gerber C, Jenkins A, Nicholson C, Todd NV, Ross N, Bhattathiri P, Nissen J, Crawford PJ, Wynne-Jones G, Sengupta RP, Graham L, Gani A, Davis M, Gray C, Barer D, Dorman P, Millar D, Williamson J, Durham H, Jones A, Hastie H, Mendelow AD. Reassessment of the HAMLET study. Lancet Neurol. 2009;8:602–3.CrossRefPubMed Mitchell P, Gregson BA, Crossman J, Gerber C, Jenkins A, Nicholson C, Todd NV, Ross N, Bhattathiri P, Nissen J, Crawford PJ, Wynne-Jones G, Sengupta RP, Graham L, Gani A, Davis M, Gray C, Barer D, Dorman P, Millar D, Williamson J, Durham H, Jones A, Hastie H, Mendelow AD. Reassessment of the HAMLET study. Lancet Neurol. 2009;8:602–3.CrossRefPubMed
11.
go back to reference Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.PubMed Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.PubMed
12.
go back to reference Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke. 1997;28:1876–82.PubMed Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke. 1997;28:1876–82.PubMed
13.
go back to reference EuroQol. A new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199–208. EuroQol. A new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199–208.
14.
go back to reference Angus DC, Carlet J. Surviving intensive care: a report from the 2002 brussels roundtable. Intensive Care Med. 2003;29:368–77.PubMed Angus DC, Carlet J. Surviving intensive care: a report from the 2002 brussels roundtable. Intensive Care Med. 2003;29:368–77.PubMed
15.
go back to reference Foerch C, Lang JM, Krause J, Raabe A, Sitzer M, Seifert V, Steinmetz H, Kessler KR. Functional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg. 2004;101:248–54.CrossRefPubMed Foerch C, Lang JM, Krause J, Raabe A, Sitzer M, Seifert V, Steinmetz H, Kessler KR. Functional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg. 2004;101:248–54.CrossRefPubMed
16.
go back to reference Benejam B, Sahuquillo J, Poca MA, Frascheri L, Solana E, Delgado P, Junqué C. Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol. 2009;256:1126–33.CrossRefPubMed Benejam B, Sahuquillo J, Poca MA, Frascheri L, Solana E, Delgado P, Junqué C. Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol. 2009;256:1126–33.CrossRefPubMed
Metadata
Title
Hemicraniectomy for Malignant Middle Cerebral Artery Infarction: Retrospective Consent to Decompressive Surgery Depends on Functional Long-Term Outcome
Authors
Ines C. Kiphuth
Martin Köhrmann
Christoph Lichy
Stefan Schwab
Hagen B. Huttner
Publication date
01-12-2010
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 3/2010
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-010-9449-8

Other articles of this Issue 3/2010

Neurocritical Care 3/2010 Go to the issue